Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1978-05-30
1980-06-24
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260410, A61K 3123, C09F 508
Patent
active
042095298
ABSTRACT:
A new compound, farnesyl carboxylic acid .alpha.-bisabolol ester is disclosed, which is a novel mucosal stabilizing agent showing anti-inflammative and anti-ulcerative activities. This new compound is especially useful in the treatment of gastric ulcer. The compound is synthesized by esterification of farnesyl carboxylic acid or its derivatives with .alpha.-bisabolol or a derivative thereof.
REFERENCES:
Chem. Abst. 9th Coll. Index, 1972-1976, Diazene-Ethaneperoxoic acid.
Adams Bruce L.
Burns Robert E.
Friedman Stanley J.
Kotobuki Seiyaku Company Limited
Lobato Emmanuel J.
LandOfFree
Farnesyl carboxylic acid .alpha.-bisabolol ester, a mucosal stab does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Farnesyl carboxylic acid .alpha.-bisabolol ester, a mucosal stab, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Farnesyl carboxylic acid .alpha.-bisabolol ester, a mucosal stab will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1480798